BioEclipse Therapeutics' Incubator/Accelerator Round

BioEclipse Therapeutics raised a round of funding on August 21, 2017. Investors include JLabs.

BioEclipse Therapeutics is a clinical-stage biopharmaceutical company committed to delivering curative immune-oncology therapeutics to patients with cancer.…

Articles about BioEclipse Therapeutics' Incubator/Accelerator Round: